Where to Start with David A. Sinclair: A Reading Guide
Where to start with David A. Sinclair — how to approach Lifespan, his essential book on the science of aging. A complete reading guide to the Harvard geneticist's work.
By Elena Marsh
David A. Sinclair (born 1969) is an Australian-American geneticist and professor in the Department of Genetics at Harvard Medical School, where he co-directs the Paul F. Glenn Center for Biology of Aging Research. His research focuses on the epigenetics of aging, the role of sirtuins as longevity proteins, and the NAD+ pathway as a target for aging interventions. Lifespan (2019), co-written with Matthew LaPlante, is his account of this research for a general audience and a statement of his central thesis: that aging is a disease, and that it is treatable.
Where to Start: Lifespan (2019)
The essential Sinclair — and the most scientifically grounded popular science book in the longevity genre. Lifespan opens with a claim that remains contested but has gained significant traction: that aging is not a natural process to be accepted but a disease to be treated. Most people die not from specific diseases — cancer, heart disease, Alzheimer’s — but from the underlying vulnerability to those diseases that aging creates. Treat aging, and you address all age-related diseases simultaneously.
Sinclair’s theoretical framework is the information theory of aging. He argues that cells age not primarily because DNA is damaged (the old theory) but because they lose the ability to correctly read their own genetic instructions — a loss of epigenetic information. The analogy he uses is a scratched CD: the music is still there, but the player can’t read it. If this is correct, aging is not the deterioration of an irreplaceable original but the degradation of a reading process — potentially reversible if the reading mechanism can be reset.
The biological mechanism Sinclair has spent his career studying is the sirtuin pathway. Sirtuins are proteins that regulate cellular health, repair DNA damage, and respond to stressors like caloric restriction and exercise. When sirtuins are activated — by dietary restriction, exercise, NAD+ precursors like NMN or NR, or certain pharmaceutical compounds — cellular maintenance improves and aging signals are suppressed. The first part of the book covers this research in depth; the second part covers the interventions — both available now and in development — that may extend healthy lifespan.
Sinclair is honest about the distance between animal research and human outcomes: the studies that show dramatic lifespan extension in mice have not consistently translated to similar effects in humans, and the field is still working out which findings are generalisable. His personal practices — intermittent fasting, NMN supplementation, resveratrol — are described as his own choices based on his reading of the evidence, not as proven recommendations. This intellectual honesty distinguishes the book from less rigorous longevity titles.
Reading David A. Sinclair
Lifespan is Sinclair’s essential and only popular science book. His research papers are available through PubMed and Google Scholar. Peter Attia’s Outlive (2023) is the natural companion for the clinical applications of longevity science.
For the full David A. Sinclair bibliography, reviews, and biography, visit the David A. Sinclair author page on Editors Reads.
Affiliate disclosure: Links to Amazon on this page are affiliate links. We earn a small commission at no extra cost to you.
Frequently Asked Questions
Where should I start with David A. Sinclair?
Lifespan (2019) is Sinclair's essential and only popular science book — his Harvard geneticist's argument that aging is a disease that can be treated, drawing on his own landmark research on sirtuins, NAD+, and the information theory of aging. The most scientifically substantial popular science book on longevity; more rigorous than most in the genre.
What is Lifespan about?
Lifespan argues that aging is not an inevitable process but a disease — specifically, a disease of lost epigenetic information. Sinclair's information theory of aging proposes that cells age because they lose the ability to read their own genetic instructions correctly, not because the DNA is damaged. The implications are significant: if aging is a loss of information rather than damage, it may be reversible if the information can be restored. Sinclair covers the research on sirtuins, NAD+ precursors, caloric restriction, mTOR pathways, and the pharmaceutical interventions that may slow or reverse aging.
Is the Lifespan science reliable?
Sinclair is a serious researcher at Harvard whose work on sirtuins and aging is published in peer-reviewed journals and is central to the longevity science field. Some colleagues have criticised the book for presenting preliminary findings with more certainty than the evidence warrants, particularly regarding the effects of NMN and resveratrol on human longevity. The theoretical framework (information theory of aging) is Sinclair's own and remains contested. The book is best read as the work of a leading scientist describing his research programme, not as established consensus.
What should I read after Lifespan?
After Lifespan, Peter Attia's Outlive (2023) covers longevity medicine from a clinical perspective with more emphasis on the practical interventions available today. Andrew Huberman's writing and podcasts cover adjacent neuroscience and performance topics. For the broader science of aging, Morgan Levine's True Age covers epigenetic aging clocks, which connect directly to Sinclair's research. Matthew Walker's Why We Sleep addresses sleep's role in longevity, which Sinclair discusses as one of the most important behavioural interventions.
